For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260316:nRSP8135Wa&default-theme=true
RNS Number : 8135W Primary Health Properties PLC 16 March 2026
Primary Health Properties PLC
("PHP" or the "Company"),
Director/PDMR Shareholding
The Company has been notified that the following information relating to the
transaction detailed below has been filed with the FCA in accordance with
Article 19(1) of the Market Abuse Regulation.
1 Details of person discharging managerial responsibilities/person closely
associated
(a) Name Harry Hyman
2 Reason for notification
(a) Position/Status Non-executive Chair
(b) Initial notification/amendment Initial notification
3 Details of the issuer, emission allowance market participant, auction
platform, auctioneer or auction monitor
(a) Name Primary Health Properties PLC
(b) LEI 213800Y5CJHXOATK7X11
4 Details of the transaction(s): section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted
(a) Description of the financial instrument Ordinary shares of 12.5p
ISIN: GB00BYRJ5J14
(b) Nature of the transaction Purchase by ISA under dividend re-investment plan
(c) Price(s) and volume(s) Price(s) Volume(s)
£ 1.01341 4,150
(d) Aggregated volume price Single transaction
£4,205.65
(e) Date of transaction 13 March 2026
(f) Place of transaction London Stock Exchange (xlon)
For further information:
Primary Health Properties PLC
David Purcell Investor Relations
Primary Health Properties PLC
T: +44 (0) 7921 190 136
E: david.purcell@phpgroup.co.uk
Sodali & Co Financial PR
Elly Williamson/Louisa Henry/Saskia Bottomley
T: +44 (0) 207 250 1446 E: PHP@client.sodali.com
(mailto:PHP@client.sodali.com)
Legal Entity Identifier: 213800Y5CJHXOATK7X11
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBDGDXIGBDGLL
Copyright 2019 Regulatory News Service, all rights reserved